	Capitaux D'Emprunt		Date
Acadia Pharmaceuticals	USD 0	0	2025-03
Adma Biologics	USD 70.08M	3.32M	2025-09
ALKERMES	USD 285.82M	639K	2024-09
Alterity Therapeutics Limited	AUD 103.21K	73.88K	2023-06
AstraZeneca	USD 6.55B	19.43B	2025-09
BioCryst Pharmaceuticals	USD 194.37M	48.43M	2025-09
Bristol-Myers Squibb	USD 42.85B	1.62B	2025-12
Cipla	INR 2.98B	454.6M	2025-09
Clal Biotechnology	ILS 25.96M	18.48M	2023-12
Compugen	USD 0	0	2024-12
CSL	USD 10.69B	1.37B	2025-06
Dynavax Technologies	USD 220.97M	214K	2025-09
Eli Lilly	USD 40.87B	6.69B	2025-09
Esperion Therapeutics	USD 262.48M	235.95M	2024-06
GlaxoSmithKline	GBP 14.71B	186M	2025-12
Grifols	EUR 10.67B	564.4M	2025-09
Halozyme Therapeutics	USD 800.07M	709.03M	2025-09
Ionis Pharmaceuticals	USD 28.78M	596.71M	2025-09
J&J	USD 39.41B	173M	2025-09
Merck	USD 39.97B	6B	2025-09
Minerva Neurosciences	USD 0	86.58M	2024-09
Neurocrine Biosciences	USD 169.5M	500K	2023-03
Novartis	USD 24.24B	174M	2025-09
Novavax	USD 223.63M	187K	2024-09
Pfizer	USD 57.41B	93M	2025-09
Roche Holding	CHF 27.43B	966M	2025-12
Sanofi	EUR 15.72B	2.45B	2025-12
Takeda	JPY 4.27T	81.29B	2025-12
Vanda Pharmaceuticals	USD 3.15M	3.15M	2024-12

Minerva Neurosciences Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.